Cite

HARVARD Citation

    Macaluso, F. et al. (2021). A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease. Journal of gastroenterology and hepatology. 36 (1), pp. 105-111. [Online]. 
  
Back to record